11 (Bloomberg) -- AstraZeneca Plc, the UK's second- largest drugmaker, asked European regulators for permission to sell anti-psychotic drug Seroquel for ...
AstraZeneca has asked for summary judgment in the case it filed to protect its ’288 patent for its bipolar disorder drug Seroquel against generic drugmakers ...
I found Seroquel and I found Beau. He has helped me greatly with his companionship and loyalty. His enthusiasm to get out and have fun helped me to get back ...
all 22 news articles
The Anglo-Swedish company, the UK's second-biggest drugmaker, has submitted applications for the use of the once-daily Seroquel XR tablets for use in the ...
Shares in Anglo-Swedish drugmaker AstraZeneca have also fallen this year, as US patent disputes over its two biggest drugs, Nexium and Seroquel, ...
Teva is challenging patents protecting Seroquel and may offer a less-expensive generic copy of the medicine in the US as early as the end of March, ...
AstraZeneca also announced it has submitted a further application in the EU for SEROQUEL® (quetiapine fumarate immediate release, IR) for the treatment of ...
From next month onward, Seroquel, a once-daily anti-psychotic drug, faces the threat of generic competition from Teva Pharmaceutical Industries Ltd. The ...
LONDON (Thomson Financial) - AstraZeneca said it has submitted a number of applications in Europe for the approval of its schizophrenia drugs Seroquel XR ...